What are the Benefits of Chromosomal Microarray in Clinical Epidemiology?
Clinical epidemiology benefits significantly from CMA by improving the accuracy of diagnosis and enabling personalized medicine. Early detection of genetic abnormalities can lead to timely interventions, reducing the burden of disease and improving patient outcomes.
